News
VRAX
3.110
-7.85%
-0.265
Virax Biolabs Group Ltd trading halted, news pending
TipRanks · 1d ago
BRIEF-Virax Biolabs Group Ltd - Announces 1-For-25 Share Consolidation
Reuters · 2d ago
Virax Biolabs Approves 1-for-25 Share Consolidation to Maintain Nasdaq Listing
TipRanks · 2d ago
Virax Biolabs approves share consolidation program
TipRanks · 2d ago
Virax Biolabs Group Announces 1-For-25 Reverse Stock Split, Effective June 26
Benzinga · 2d ago
Virax Biolabs to consolidate shares 1-for-25 on June 26
PUBT · 2d ago
Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation
PR Newswire · 2d ago
Weekly Report: what happened at VRAX last week (0615-0619)?
Weekly Report · 4d ago
Weekly Report: what happened at VRAX last week (0608-0612)?
Weekly Report · 06/15 09:44
Virax Biolabs Shareholders Approve Reverse Split and Amended Charter at June 12 Meeting
TipRanks · 06/12 13:57
Virax Biolabs adjourns shareholder meeting after failing to reach quorum
PUBT · 06/12 13:25
Weekly Report: what happened at VRAX last week (0601-0605)?
Weekly Report · 06/08 09:42
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 06/04 12:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 06/03 21:07
Weekly Report: what happened at VRAX last week (0525-0529)?
Weekly Report · 06/01 09:44
Virax Biolabs reports pilot data for ViraxImmune in Long COVID
TipRanks · 05/26 13:04
Virax Biolabs Reports Strong Early Data for Long COVID Test and Prepares Larger Validation Study
TipRanks · 05/26 12:02
Virax Biolabs posts early pilot data for ViraxImmune Long COVID test, reports 88% specificity
PUBT · 05/26 11:31
VIRAX BIOLABS REPORTS POSITIVE EARLY CLINICAL DATA FOR VIRAXIMMUNE™ IN LONG COVID AND RELATED POST-ACUTE INFECTION SYNDROMES
Reuters · 05/26 11:31
Weekly Report: what happened at VRAX last week (0518-0522)?
Weekly Report · 05/25 09:46
More
Webull provides a variety of real-time VRAX stock news. You can receive the latest news about Virax Biolabs Group Ltd through multiple platforms. This information may help you make smarter investment decisions.
About VRAX
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).